HRA® offers compensation of $500 to physicians for your consultative contributions during the event discussions, responses to polling questions and completion of a post-event survey.

Please note: this is a non-CME, independently produced program. All content is developed by the HCPLive® team.

OVERVIEW

HCPLive® Clinical Forum are regional roundtable discussions where an expert moderator has the opportunity to directly engage with health care professionals (HCPs) to present data, medical advances, and patient case scenarios. This leads to a moderated forum between attendees to gather insights on their community practice implementation of new science, feedback on case scenarios, as well as other information which impact the clinical decision making of local HCPs.

These forums serve as a platform for localized education and peer-to-peer collaborative discussions aiming to ultimately elevate and improve patient care. 

LEARNING OBJECTIVES

• Identify patients at increased risk for chronic kidney disease (CKD), particularly those with cardiovascular disease (CVD) and type 2 diabetes (T2D), and recognize clinical and demographic factors that warrant early and confirmatory testing.
• Evaluate the clinical utility and interpretation of key biomarkers (e.g., uACR, eGFR, and albuminuria) in the detection, staging, and risk stratification of CKD.
• Describe how early risk recognition influences clinical decision-making, including appropriate screening intervals and care pathway optimization across specialties.

This event is held in partnership with Healthcare Research & Analytics (HRA®) to gain valuable insights into health care professional’s educational needs in their current practice setting.   

HRA® offers compensation of $500 to physicians for your consultative contributions during the event discussions, responses to polling questions and completion of a post-event survey. 

Copyright HCPLive 2025.

All Rights Reserved.

Terms & Conditions

Privacy Policy

Contact Us: events@hcplive.com